Merrion Pharma to hand back €4.5m to investors in liquidation
Drug company announced it planned to voluntarily wind up
Merrion Pharma is understood to be contacting broking firms to advise clients to vote on the company’s winding-up plan.
Merrion, a drug company backed by Declan Ryan, announced last month that it planned to voluntarily wind up and hand back €4.5 million of cash to investors. After selling intellectual property assets last year to drug giant Novo, Nordisk Merrion set about turning itself into an investment company focused on the healthcare sector, but ...